ALS is incurable -- it’s a progressive attack on nerve cells that control voluntary movements--like breathing. We meet two men diagnosed with ALS: Ed Rapp, and Peter Warlick, who are raising awareness and millions of dollars for ‘Answer ALS,’ an unorthodox way to crowdsource research.
And we talk to the research director, Dr. Jeffrey Rothstein, about how the Answer ALS approach mimics research on cancer, by applying stem cell technology.
Thomas Rowe Price Junior, born in Baltimore County at the end of the nineteenth century, set out to be an industrial chemist, but fell in love with investing--choosing stocks by analyzing how a company will add value to the economy.
His biographer, Cornelius Bond, says by the time he set up T. Rowe Price & Associates a few years after the Great Depression, Price on a different path than other investment managers.
Thousands of blind people travel and commute every day. But they can face challenges, barriers--even discrimination--along the way. Stacey Cervenka, who is blind, tells us about her plans for a Blind Traveler’s Network, a website to provide tips and recommendations for accessible vacation travel. She's a winner of the 2018 Holman Prize for Blind Ambition.
And we meet Mark Riccobono, president of the National Federation of the Blind. He discusses advocacy for equal treatment and access for blind and visually impaired people, and notes that people's perceptions of what it's like to be blind is often the toughest thing to overcome.